Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Arcutis Biotherapeutics, Inc.

NASDAQ: ARQT · Life Sciences · 8 alerts · CIK 1787306

Share price
$27.15Close, Nov 16
Market cap
$3.43B
Shares outstanding
126.46MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Arcutis Biotherapeutics, Inc. filings on SEC EDGAR ↗

9:04 AM ET 8-K
Leadership Change

Arcutis Biotherapeutics Leadership Change

Arcutis Biotherapeutics appointed Dr. Robert Scott to its Board of Directors and the Nominating and Corporate Governance Committee, effective October 23, 2026. Dr. Scott, a former Chief Medical Officer at AbbVie and Amgen, joins as a Class II director with a term expiring in 2028. As part of his appointment, he received an initial stock option award for 20,507 shares of common stock.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.